Sichuan Goldstone Asia Pharmaceutical Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 535.535 million compared to CNY 337.250 million a year ago. Operating income was CNY 88.330 million compared to CNY 8.341 million a year ago. Net income was CNY 74.131 million compared to CNY 3.789 million a year ago. Basic earnings per share from continuing operations was CNY 0.1845 compared to CNY 0.01 a year ago.